Skip to main content
. 2007 Nov 13;97(10):1338–1343. doi: 10.1038/sj.bjc.6604043

Table 4. Summary of PK parameters for pertuzumab in combination with docetaxel.

Dose (mg) Cycle t1/2 (day) Mean (range) Cmax (μg ml−1) mean (range) AUC0-last (μg day ml−1) mean (range) AUC0-∞ (μg day ml−1) Mean (range) Vss (ml) mean (range) Cl (ml per day) mean (range)
1050 n=8 1 13.36 (7.80–19.59) 301 (143–394) 2390 (1733–3355) 3951 (2348–4980) 5214 (2975–7036) 282 (211–447)
1050 n=7 2 22.08 (9.02–49.63) 368 (253–463) 3500 (3010–4346) 6856 (4521–11426) 4672 (3023–6580) 167 (92 232)
840 n=11 1 12.13 (6.95–25.96) 255 (169–447) 1749 (1214–3083) 2796 (1604–5116) 5355 (3028–8217 329 (164–524)
420 n=10 2 19.10 (8.85–42.00) 150 (102–233) 1491 (914–2289) 2762 (1639–3827) 4233 (2823–7058) 169 (110–256)